Pharmaceutical giant AstraZeneca has admitted that its Covid-19 vaccine can cause a rare side effect known as Thrombosis with Thrombocytopenia Syndrome' (TTS), according to a report by the London ...

截至目前为止，澳洲已经为民众接种210万剂阿斯利康疫苗，其中只有24例出现TTS罕见血栓的病例。按此计算，出现TTS的机率是88000分之一。 有关比率 ...

On April 30, AstraZeneca conceded the vaccine, sold under the name Vaxzevria, can cause fatal blood clots and low platelet counts, also known as thrombosis with thrombocytopenia syndrome, or TTS.

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

We readied to overcome a threat to vaccine trust Earlier this year, Vaxzevria, AstraZeneca's 'viral vector' COVID-19 vaccine, was battling perception issues, with stakeholders holding the ...